F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to maintain complete and accurate medical records in
accordance with accepted professional standards for one of three sampled residents (Residents 1) by
failing to ensure the licensed nursing staff would not sign Resident 1's Medication Administration Record for
antibiotic (a type of medication used to treat or prevent bacterial infections by killing bacteria or stopping
their growth) therapy on three different dates (9/20/2025, 9/23/2025, and 9/25/2025) when the medication
had not been delivered to the facility. This deficient practice resulted in the medical record inaccurately
representing care Resident 1 did not receive and had the potential to place the resident at risk for
worsening infection. Findings: During a review of Resident 1's admission Record, the admission Record
indicated Resident 1 was admitted on [DATE] and readmitted on [DATE] with medical diagnosis including
multiple sclerosis (a disease in which the immune system eats away at the covering of nerves), sepsis ( a
life threatening complication of an infection), urinary tract infection (bladder infection), pressure ulcer stage
three (full-thickness loss of skin where dead and black tissue may be visible), and neuromuscular
dysfunction of bladder (bladder injury). During a review of Resident 1's Minimum Data Set (MDS - a
resident assessment tool), dated 8/28/2025, the MDS indicated Resident 1 was cognitively intact and was
dependent on staff for activities of daily living (ADLs - activities such as bathing, dressing and toileting a
person performs daily). During a review of Resident 1's Physician Orders, dated 9/20/2025, the physician's
order indicated an order for Fidaxomicin (an antibiotic used to treat c-diff-inflammation of the colon) oral
tablet 200 mg (milligram - a unit of measure fpr mass) give one tablet by mouth two times a day for C-diff
(inflammation of the colon caused by an infection) for seven days. During a review of Resident 1's
Medication Administration Record, dated September 2025, the MAR indicated Fidaxomicin was
administered to Resident 1 on 9/20/2025, 9/23/2025, and 9/25/2025. During a concurrent interview and
record review with the Registered Nurse (RN) 1 on 9/30/2025 at 8:50 a.m., Resident 1's Change of
Condition (COC), dated 9/28/2025, was reviewed and indicated Resident 1's antibiotic medication was not
delivered and administered to Resident 1. RN 1 stated a COC was initiated and the physician was notified
that Resident 1's Medication Administration Record reflected the antibiotic was given on three different
occasions, 9/20/2025, 9/23/2025 and 9/25/2025, however the medication had not been delivered to the
facility until 9/28/2025. During an interview with the Pharmacist (PH) on 9/30/2/25 at 2:00 p.m., the PH
stated the pharmacy first delivered the Resident 1's antibiotic medication on 9/28/2025. During an interview
with the Director of Nurses (DON) on 9/30/2025 at 4:30 p.m., the DON stated the pharmacy delivered
Resident 1's antibiotic on 9/28/2025 due to authorization problems. The DON stated the physician was
called to notify him the medication was not getting authorized, and to order a different medication. The DON
stated the physician did not order another medication. The DON stated the facility initiated a change of
condition for the medication
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
055932
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055932
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/04/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Four Seasons Healthcare & Wellness Center, LP
5335 Laurel Canyon Blvd.
North Hollywood, CA 91607
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
that was charted in error. During a review of the facility's policy and procedure (P&P) titled, Completion and
Correction, 1/1/2012, the P&P indicated the facility will work to complete and correct medical records in a
standardized manner to provide the highest quality and accuracy in documentation. Entries will be
recorders promptly as the events or observations occur. Entries will be complete, legible, descriptive, and
accurate.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055932
If continuation sheet
Page 2 of 2